Investigation of inducible clindamycin and telithromycin resistance in isolates of β-hemolytic streptococci

Diagnostic Microbiology and Infectious Disease

Volumn 55, Issue 3, 2006, Pages 213-218

  Raney, Patti M ^a   Tenover, Fred C ^a   Carey, Roberta B ^a   McGowan Jr , John E ^b   Patel, Jean B ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

D zone test; Erythromycin; Streptococci

Indexed keywords

CLINDAMYCIN; ERM PROTEIN; ERYTHROMYCIN; MEF PROTEIN; PROTEIN; TELITHROMYCIN; UNCLASSIFIED DRUG;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; RELIABILITY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; HEMOLYSIN PROTEINS; HUMANS; KETOLIDES; MACROLIDES; MEMBRANE PROTEINS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS;

EID: 33745249533     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.01.013     Document Type: Article

References (21)

1. Betriu C., Culebras E., Gomez M., Rodriguez-Avial I., Sanchez B.A., Agreda M.C., and Picazo J.J. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob. Agents Chemother. 47 (2003) 1112-1114
2. Clinical and Laboratories Standards Institute. Performance standards for antimicrobial susceptibility testing fifteenth informational supplement M100-S15 (2005), CLSI, Wayne (PA)
3. Davis K.A., Crawford S.A., Fiebelkorn K.R., and Jorgensen J.H. Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp. Antimicrob. Agents Chemother. 49 (2005) 3059-3061
4. Douthwaite S., Jalava J., and Jakobsen L. Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm. Mol. Microbiol. 58 (2005) 613-622
5. Fiebelkorn K.R., Crawford S.A., McElmeel M.L., and Jorgensen J.H. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiol. 41 (2003) 4740-4744
6. Fines M., Gueudin M., Ramon A., and Leclercq R. In vitro selection of resistance to clindamycin related to alterations in the attenuator of the erm(TR) gene of Streptococcus pyogenes UCN1 inducibly resistant to erythromycin. J. Antimicrob. Chemother. 48 (2001) 411-416
7. Fridkin S.K., Steward C.D., Edwards J.R., Pryor E.R., McGowan Jr. J.E., Archibald L.K., Gaynes R.P., and Tenover F.C. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin. Infect. Dis. 29 (1999) 245-252
8. Hasenbein M.E., Warner J.E., Lambert K.G., Cole S.E., Onderdonk A.B., and McAdam A.J. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J. Clin. Microbiol. 42 (2004) 1559-1563
9. Heelan J.S., Hasenbein M.E., and McAdam A.J. Resistance of group B Streptococcus to selected antibiotics, including erythromycin and clindamycin. J. Clin. Microbiol. 42 (2004) 1263-1264
10. Jalava J., Kataja J., Seppala H., and Huovinen P. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob. Agents Chemother. 45 (2001) 789-793
11. Jorgensen J.H., Crawford S.A., McElmeel M.L., and Fiebelkorn K.R. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J. Clin. Microbiol. 42 (2004) 1800-1802
12. Kaieda S., Okitsu N., Yano H., Hosaka Y., Nakano R., Okamoto R., Takahashi H., and Inoue M. Induction of telithromycin resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 52 (2003) 736-737
13. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34 (2002) 482-492
14. Lewis II J.S., and Jorgensen J.H. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned?. Clin. Infect. Dis. 40 (2005) 280-285
15. National Committee for Clinical laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A6. 6th ed. (2003), NCCLS, Wayne (PA)
16. National Committee for Clinical laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8. 8th ed. (2003), NCCLS, Wayne (PA)
17. Stevens D.L. The flesh-eating bacterium: what's next?. J. Infect. Dis. 179 Suppl 2 (1999) S366-S374
18. Steward C.D., Raney P.M., Morrell A.K., Williams P.P., McDougal L.K., Jevitt L., McGowan Jr. J.E., and Tenover F.C. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J. Clin. Microbiol. 43 (2005) 1716-1721
19. Tang P., Ng P., Lum M., Skulnick M., Small G.W., Low D.E., Sarabia A., Mazzulli T., Wong K., Simor A.E., and Willey B.M. Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococci. J. Clin. Microbiol. 42 (2004) 2282-2284
20. Turng B., Henrich L., Sinha J., Votta M., Yu C., and Reuben J. Evaluation of multiplex PCR for the detection of macrolide resistance among Streptococcus species, abstr. D-1888. Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL (2003)
21. Weisblum B. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39 (1995) 797-805